Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et al

Bibliographic Details
Format: Article
Language:English
Published: Innovative Healthcare Institute 2021-08-01
Series:Journal of Immunotherapy and Precision Oncology
Online Access:https://jipo.org/doi/pdf/10.36401/JIPO-21-CX3
_version_ 1797962768594239488
collection DOAJ
first_indexed 2024-04-11T01:18:03Z
format Article
id doaj.art-0bdb0a7fc9474ea2892b2b4dd52079a6
institution Directory Open Access Journal
issn 2666-2345
2590-017X
language English
last_indexed 2024-04-11T01:18:03Z
publishDate 2021-08-01
publisher Innovative Healthcare Institute
record_format Article
series Journal of Immunotherapy and Precision Oncology
spelling doaj.art-0bdb0a7fc9474ea2892b2b4dd52079a62023-01-03T16:42:11ZengInnovative Healthcare InstituteJournal of Immunotherapy and Precision Oncology2666-23452590-017X2021-08-0117517510.36401/JIPO-21-CX3i2590-017X-4-3-175Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et alhttps://jipo.org/doi/pdf/10.36401/JIPO-21-CX3
spellingShingle Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et al
Journal of Immunotherapy and Precision Oncology
title Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et al
title_full Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et al
title_fullStr Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et al
title_full_unstemmed Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et al
title_short Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et al
title_sort correction notice for first line parp inhibitors emerging side effects require caution a case of parpi induced pneumonitis by mclaren et al
url https://jipo.org/doi/pdf/10.36401/JIPO-21-CX3